We are live on ! Find out more
BE

Bonness Enterprises Portfolio holdings

AUM $310M
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$218M
AUM Growth
-$3.99M
Cap. Flow
-$33.8K
Cap. Flow %
-0.02%
Top 10 Hldgs %
70.33%
Holding
40
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$33.8K

Sector Composition

Rank Sector Weight
1 Financials 39.58%
2 Healthcare 27.34%
3 Technology 21.07%
4 Industrials 3.58%
5 Consumer Staples 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGR icon
1
Progressive
PGR
$122B
$79.1M 36.24%
567,757
– –
SYK icon
2
Stryker
SYK
$128B
$18.3M 8.41%
67,130
– –
MSFT icon
3
Microsoft
MSFT
$3.59T
$12.9M 5.92%
40,900
– –
AAPL icon
4
Apple
AAPL
$4.48T
$9.41M 4.31%
54,940
– –
MRK icon
5
Merck
MRK
$317B
$7.16M 3.28%
69,500
– –
JNJ icon
6
Johnson & Johnson
JNJ
$609B
$6.05M 2.77%
38,838
– –
TMO icon
7
Thermo Fisher Scientific
TMO
$214B
$5.56M 2.55%
10,985
– –
ABBV icon
8
AbbVie
ABBV
$435B
$5.5M 2.52%
36,900
– –
MRSH
9
Marsh
MRSH
$91.4B
$4.85M 2.22%
25,500
– –
INTC icon
10
Intel
INTC
$457B
$4.62M 2.12%
129,950
– –
CSCO icon
11
Cisco
CSCO
$455B
$4.45M 2.04%
82,700
– –
AMAT icon
12
Applied Materials
AMAT
$408B
$4.33M 1.99%
31,300
– –
NUE icon
13
Nucor
NUE
$58.5B
$4.29M 1.97%
27,435
– –
EMR icon
14
Emerson Electric
EMR
$85.4B
$4.15M 1.9%
43,000
– –
IBM icon
15
IBM
IBM
$213B
$4.15M 1.9%
29,564
– –
UL icon
16
Unilever
UL
$137B
$3.76M 1.72%
67,591
– –
PFE icon
17
Pfizer
PFE
$143B
$3.64M 1.67%
109,708
– –
ABT icon
18
Abbott
ABT
$185B
$3.17M 1.45%
32,700
– –
BMY icon
19
Bristol-Myers Squibb
BMY
$133B
$3.15M 1.44%
54,300
– –
PG icon
20
Procter & Gamble
PG
$337B
$2.39M 1.1%
16,400
– –
UPS icon
21
United Parcel Service
UPS
$90.6B
$2.33M 1.07%
14,950
– –
PHG icon
22
Philips
PHG
$25.6B
$2.03M 0.93%
113,544
– –
A icon
23
Agilent Technologies
A
$39.2B
$2M 0.92%
17,900
– –
GSK icon
24
GSK
GSK
$103B
$1.92M 0.88%
52,960
– –
WLY icon
25
John Wiley & Sons Class A
WLY
$2.67B
$1.8M 0.82%
48,400
– –
1
2

Similar funds

IPW
IronBridge Private Wealth Austin, Texas $310M AUM 41.13% 1-Year Est. Return
TL
Tradewinds LLC Raleigh, North Carolina $310M AUM 22.31% 1-Year Est. Return
RGC
Redwood Grove Capital Palo Alto, California $310M AUM 35.87% 1-Year Est. Return
IR
IAT Reinsurance New York $310M AUM 13.37% 1-Year Est. Return
TWM
TSA Wealth Management Houston, Texas $309M AUM 15.82% 1-Year Est. Return
PH
Pinnacle Holdings Tulsa, Oklahoma $309M AUM 18.8% 1-Year Est. Return
CCG
Cloverfields Capital Group Minneapolis, Minnesota $309M AUM 20.93% 1-Year Est. Return
FI
Financial Insights Tacoma, Washington $309M AUM 17.27% 1-Year Est. Return

Bonness Enterprises's Q3 2023 Portfolio in Review

As of Q3 2023, Bonness Enterprises held 40 positions worth $218M, down 1.8% from $222M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. Bonness Enterprises opened no new positions and made no exits, leaving the 40-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 37% a quarter earlier, followed by Healthcare and Technology.

  • Bonness Enterprises's biggest Q3 2023 reduction was Verizon, cutting an estimated $33.8K.
  • Bonness Enterprises's ten largest holdings make up 70% of its $218M portfolio in Q3 2023.
  • Bonness Enterprises opened 0 new positions and closed 0 in Q3 2023.
  • Bonness Enterprises's portfolio value fell 1.8% quarter-over-quarter to $218M.

Based on Bonness Enterprises's 13F filing for Q3 2023, filed 18 Oct 2023.